EGFR exon 21 L858R as an acquired resistance mechanism to nivolumab in a lung cancer patient originally driver gene‐negative

por Xia, Chen, Zeng, Fanxu, Zhang, Yongchang
Publicado 2019

Acrylamide exposure impairs blood-cerebrospinal fluid barrier function

por Yao, Xue, Yan, Licheng, Yao, Lin, Guan, Weijun, Zeng, Fanxu, Cao, Fuyuan, Zhang, Yanshu
Publicado 2014

The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer

por Chen, Gong, Chen, Qiong, Zeng, Fanxu, Zeng, Liang, Yang, Haiyan, Xiong, Yi, Zhou, Chunhua, Liu, Li, Jiang, Wenjuan, Yang, Nong, Zhang, Yongchang
Publicado 2017

PD-1 inhibitor versus bevacizumab in combination with platinum-based chemotherapy for first-line treatment of advanced lung adenocarcinoma: A retrospective-real world study

por Huang, Zhe, Zhou, Chunhua, Xiong, Yi, Yang, Feng, Zeng, Fanxu, Jiang, Wenjuan, Zhang, Yongchang, Yang, Haiyan, Liu, Li, Zeng, Liang, Yang, Nong, Wang, Zhan
Publicado 2022

Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer

por Liu, Chaoyuan, Zeng, Liang, Deng, Chao, Jiang, Wenjuan, Wang, Yapeng, Zhou, Yiguang, Liu, Li, Wang, Sisi, Zhou, Chunhua, Qiu, Zhenhua, Zeng, Fanxu, Wu, Fang, Weng, Jie, Liu, Xianling, Yang, Nong, Ma, Fang
Publicado 2023